OFIX
Income statement / Annual
Last year (2023), Orthofix Medical Inc.'s total revenue was $746.64 M,
an increase of 62.06% from the previous year.
In 2023, Orthofix Medical Inc.'s net income was -$151.40 M.
See Orthofix Medical Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$746.64 M
|
$460.71 M
|
$464.48 M
|
$406.56 M
|
$459.96 M
|
$453.04 M
|
$433.82 M
|
$409.79 M
|
$396.49 M
|
$402.28 M
|
| Cost of Revenue |
$260.37 M |
$123.54 M |
$114.91 M |
$101.89 M |
$100.61 M |
$96.63 M |
$93.04 M |
$87.85 M |
$86.53 M |
$98.91 M |
| Gross Profit |
$486.27 M |
$337.17 M |
$349.57 M |
$304.67 M |
$359.35 M |
$356.41 M |
$340.79 M |
$321.94 M |
$309.96 M |
$303.37 M |
| Gross Profit Ratio |
0.65 |
0.73 |
0.75 |
0.75 |
0.78 |
0.79 |
0.79 |
0.79 |
0.78 |
0.75 |
| Research and Development
Expenses |
$80.23 M
|
$49.07 M
|
$49.62 M
|
$39.06 M
|
$34.64 M
|
$33.22 M
|
$29.70 M
|
$28.80 M
|
$26.39 M
|
$24.99 M
|
| General & Administrative
Expenses |
$144.66 M
|
$79.97 M
|
$69.35 M
|
$67.95 M
|
$85.61 M
|
$84.51 M
|
$74.39 M
|
$74.40 M
|
$87.16 M
|
$76.79 M
|
| Selling & Marketing
Expenses |
$385.74 M
|
$228.81 M
|
$221.32 M
|
$204.43 M
|
$223.68 M
|
$205.53 M
|
$198.37 M
|
$181.29 M
|
$178.08 M
|
$166.55 M
|
| Selling, General &
Administrative Expenses |
$530.40 M
|
$308.78 M
|
$290.67 M
|
$272.38 M
|
$309.28 M
|
$290.03 M
|
$272.76 M
|
$255.69 M
|
$265.24 M
|
$243.34 M
|
| Other Expenses |
$14.76 M |
-$3.15 M |
-$3.34 M |
$8.38 M |
-$8.14 M |
-$6.38 M |
-$4.00 M |
-$17.18 M |
-$259,000.00 |
-$2.90 M |
| Operating Expenses |
$667.43 M |
$357.84 M |
$340.29 M |
$311.44 M |
$343.92 M |
$323.25 M |
$302.46 M |
$284.49 M |
$291.63 M |
$270.62 M |
| Cost And Expenses |
$885.75 M |
$481.39 M |
$455.21 M |
$413.33 M |
$444.53 M |
$419.88 M |
$395.50 M |
$372.35 M |
$378.15 M |
$369.53 M |
| Interest Income |
$0.00 |
$1.29 M |
$1.84 M |
$2.48 M |
$122,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$8.63 M |
$1.29 M |
$1.84 M |
$2.48 M |
$122,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$53.06 M
|
$29.02 M
|
$29.60 M
|
$30.55 M
|
$24.70 M
|
$18.66 M
|
$20.12 M
|
$20.84 M
|
$20.92 M
|
$2.28 M
|
| EBITDA |
-$86.99 M
|
$12.60 M
|
$17.94 M
|
$32.66 M
|
-$2.23 M
|
$41.54 M
|
$60.94 M
|
$39.87 M
|
$29.92 M
|
$40.64 M
|
| EBITDA Ratio |
-0.12 |
-0.05 |
0.06 |
0.09 |
0.11 |
0.08 |
0.08 |
0.1 |
0.07 |
0.13 |
| Operating Income Ratio
|
-0.19
|
-0.04
|
-0.01
|
0
|
0.05
|
0.07
|
0.09
|
0.05
|
0.02
|
0.04
|
| Total Other
Income/Expenses Net |
-$9.57 M
|
-$4.44 M
|
-$5.18 M
|
-$366,500.00
|
-$8.27 M
|
-$7.21 M
|
-$4.42 M
|
-$2.04 M
|
-$748,000.00
|
-$4.68 M
|
| Income Before Tax |
-$148.68 M |
-$17.71 M |
-$13.50 M |
-$368,000.00 |
-$27.05 M |
$22.89 M |
$36.39 M |
$19.02 M |
$8.51 M |
$12.46 M |
| Income Before Tax Ratio
|
-0.2
|
-0.04
|
-0.03
|
-0
|
-0.06
|
0.05
|
0.08
|
0.05
|
0.02
|
0.03
|
| Income Tax Expense |
$2.72 M |
$2.04 M |
$24.88 M |
-$2.89 M |
$1.41 M |
$9.07 M |
$29.10 M |
$15.53 M |
$10.85 M |
$16.20 M |
| Net Income |
-$151.40 M |
-$19.75 M |
-$38.38 M |
$2.52 M |
-$28.46 M |
$13.81 M |
$6.22 M |
$3.06 M |
-$2.81 M |
-$8.54 M |
| Net Income Ratio |
-0.2 |
-0.04 |
-0.08 |
0.01 |
-0.06 |
0.03 |
0.01 |
0.01 |
-0.01 |
-0.02 |
| EPS |
-4.12 |
-0.98 |
-1.95 |
0.13 |
-1.51 |
0.75 |
0.34 |
0.17 |
-0.15 |
-0.46 |
| EPS Diluted |
-4.12 |
-0.98 |
-1.95 |
0.13 |
-1.51 |
0.73 |
0.34 |
0.17 |
-0.15 |
-0.46 |
| Weighted Average Shares
Out |
$36.73 M
|
$20.05 M
|
$19.69 M
|
$19.27 M
|
$18.90 M
|
$18.49 M
|
$18.12 M
|
$18.14 M
|
$18.80 M
|
$18.46 M
|
| Weighted Average Shares
Out Diluted |
$36.73 M
|
$20.05 M
|
$19.69 M
|
$19.39 M
|
$18.90 M
|
$18.91 M
|
$18.50 M
|
$18.46 M
|
$18.80 M
|
$18.46 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
